Table 1.
Outcome of ASCT in high-risk AIDS lymphoma
BEAM indicates carmustine (bis-chloroethylnitrosourea-BCNU), etoposide, cytarabine (arabinofuranosyl cytidine), melphalan; CY, cyclophosphamide; TBI, total body irradiation; VP16, etoposide; BU, busulfan; and PFS, progression-free survival.
